(NASDAQ: STAA) Staar Surgical Co's forecast annual revenue growth rate of 8.32% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 7.16%, and it is also forecast to beat the US market's average forecast revenue growth rate of 8.25%.
Staar Surgical Co's revenue in 2024 is $332,942,000.On average, 6 Wall Street analysts forecast STAA's revenue for 2024 to be $16,899,642,841, with the lowest STAA revenue forecast at $16,698,905,752, and the highest STAA revenue forecast at $16,979,770,437. On average, 6 Wall Street analysts forecast STAA's revenue for 2025 to be $19,093,289,487, with the lowest STAA revenue forecast at $18,361,959,166, and the highest STAA revenue forecast at $19,522,800,946.
In 2026, STAA is forecast to generate $21,687,574,112 in revenue, with the lowest revenue forecast at $20,302,925,972 and the highest revenue forecast at $23,143,053,276.